Thymus-Derived Regulatory T Cells Infiltrate the Cardiac Allograft Before Rejection
FOXP3+ regulatory T cells (Treg) either originate in the thymus (natural [n]Treg) or are induced in the periphery by antigen exposure and cytokines (induced [i]Treg). It is currently not elucidated which and to what extent these Treg subsets regulate intracardiac allogeneic responses in transplant p...
Gespeichert in:
Veröffentlicht in: | Transplantation 2015-09, Vol.99 (9), p.1839-1846 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1846 |
---|---|
container_issue | 9 |
container_start_page | 1839 |
container_title | Transplantation |
container_volume | 99 |
creator | Boer, Karin Caliskan, Kadir Peeters, Annemiek M A van Groningen, Marian C Samsom, Janneke N Maat, Alexander P W M Betjes, Michiel G H Weimar, Willem Baan, Carla C |
description | FOXP3+ regulatory T cells (Treg) either originate in the thymus (natural [n]Treg) or are induced in the periphery by antigen exposure and cytokines (induced [i]Treg). It is currently not elucidated which and to what extent these Treg subsets regulate intracardiac allogeneic responses in transplant patients.
By using demethylation of the Treg-specific demethylated region in the FOXP3 gene as a marker for nTreg and FOXP3 messenger RNA expression as a marker for the total Treg population, we examined Treg in endomyocardial biopsies (EMBs) of both patients who developed an acute rejection necessitating therapy (rejectors; International Society for Heart and Lung Transplantation rejection grade ≥ 2R) and patients who remained free from rejection (nonrejectors).
In the presence of comparable messenger RNA levels of CD3, IL-10, TGFβ, IL2, IFNγ, and IL17A, the percentage of nTreg was significantly higher in EMB with histological signs of mild rejection (rejection grade 1R) collected before rejection than in 1R EMB of nonrejectors. The total Treg population was comparable in 1R EMB of nonrejectors and 1R EMB collected before rejection, which suggests the presence of iTreg in the EMB of nonrejectors. The relative high percentage of nTreg after rejection was not related to the number of rejections, whereas the total Treg population was inversely related to the number of rejections the first year after transplantation.
Our data indicate that intragraft nTreg are unable to restrain alloreactivity leading to rejection. Moreover, the indirect evidence of the presence of intragraft iTreg suggests a possible role of iTreg in the regulation of alloreactivity. |
doi_str_mv | 10.1097/TP.0000000000000730 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1765990725</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1765990725</sourcerecordid><originalsourceid>FETCH-LOGICAL-c388t-f4042026b3797cb71fd535e5adbdcdb71b73ec278d7505e43d29cb5bb8d8c0723</originalsourceid><addsrcrecordid>eNqNkN9LwzAQx4Mobk7_AkHy6Etn0jRN-jjnr8HAofW5pMl162jXmaTC_nsjmyI-eS_Hwed7d3wQuqRkTEkmbvLFmPwuwcgRGlLOkiglkhyjISEJjShjYoDOnFsHhjMhTtEg5lKmGRVD9Jqvdm3vojuw9QcY_ALLvlG-szuc4yk0jcOzTVU33ioP2K8AT5U1tdJ40jTd0qrK41uoOgshugbt625zjk4q1Ti4OPQRenu4z6dP0fz5cTadzCPNpPRRlZAkJnFaMpEJXQpaGc44cGVKo02YS8FAx0IawQmHhJk40yUvS2mkJiJmI3S937u13XsPzhdt7XT4WW2g611BRcqzLJD8HyiRlMvgLqBsj2rbOWehKra2bpXdFZQUX-KLfFH8FR9SV4cDfdmC-cl8m2afG4p9RQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1708158534</pqid></control><display><type>article</type><title>Thymus-Derived Regulatory T Cells Infiltrate the Cardiac Allograft Before Rejection</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Boer, Karin ; Caliskan, Kadir ; Peeters, Annemiek M A ; van Groningen, Marian C ; Samsom, Janneke N ; Maat, Alexander P W M ; Betjes, Michiel G H ; Weimar, Willem ; Baan, Carla C</creator><creatorcontrib>Boer, Karin ; Caliskan, Kadir ; Peeters, Annemiek M A ; van Groningen, Marian C ; Samsom, Janneke N ; Maat, Alexander P W M ; Betjes, Michiel G H ; Weimar, Willem ; Baan, Carla C</creatorcontrib><description>FOXP3+ regulatory T cells (Treg) either originate in the thymus (natural [n]Treg) or are induced in the periphery by antigen exposure and cytokines (induced [i]Treg). It is currently not elucidated which and to what extent these Treg subsets regulate intracardiac allogeneic responses in transplant patients.
By using demethylation of the Treg-specific demethylated region in the FOXP3 gene as a marker for nTreg and FOXP3 messenger RNA expression as a marker for the total Treg population, we examined Treg in endomyocardial biopsies (EMBs) of both patients who developed an acute rejection necessitating therapy (rejectors; International Society for Heart and Lung Transplantation rejection grade ≥ 2R) and patients who remained free from rejection (nonrejectors).
In the presence of comparable messenger RNA levels of CD3, IL-10, TGFβ, IL2, IFNγ, and IL17A, the percentage of nTreg was significantly higher in EMB with histological signs of mild rejection (rejection grade 1R) collected before rejection than in 1R EMB of nonrejectors. The total Treg population was comparable in 1R EMB of nonrejectors and 1R EMB collected before rejection, which suggests the presence of iTreg in the EMB of nonrejectors. The relative high percentage of nTreg after rejection was not related to the number of rejections, whereas the total Treg population was inversely related to the number of rejections the first year after transplantation.
Our data indicate that intragraft nTreg are unable to restrain alloreactivity leading to rejection. Moreover, the indirect evidence of the presence of intragraft iTreg suggests a possible role of iTreg in the regulation of alloreactivity.</description><identifier>ISSN: 0041-1337</identifier><identifier>EISSN: 1534-6080</identifier><identifier>DOI: 10.1097/TP.0000000000000730</identifier><identifier>PMID: 25886917</identifier><language>eng</language><publisher>United States</publisher><subject>Acute Disease ; Adolescent ; Adult ; Aged ; Biopsy ; Chemotaxis, Leukocyte ; DNA Methylation ; Female ; Forkhead Transcription Factors - genetics ; Genetic Markers ; Graft Rejection - drug therapy ; Graft Rejection - genetics ; Graft Rejection - immunology ; Graft Rejection - pathology ; Heart Transplantation - adverse effects ; Humans ; Immunohistochemistry ; Immunosuppressive Agents - therapeutic use ; Male ; Middle Aged ; Myocardium - immunology ; Myocardium - pathology ; Real-Time Polymerase Chain Reaction ; RNA, Messenger - genetics ; T-Lymphocytes, Regulatory - immunology ; Thymocytes - immunology</subject><ispartof>Transplantation, 2015-09, Vol.99 (9), p.1839-1846</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c388t-f4042026b3797cb71fd535e5adbdcdb71b73ec278d7505e43d29cb5bb8d8c0723</citedby><cites>FETCH-LOGICAL-c388t-f4042026b3797cb71fd535e5adbdcdb71b73ec278d7505e43d29cb5bb8d8c0723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25886917$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boer, Karin</creatorcontrib><creatorcontrib>Caliskan, Kadir</creatorcontrib><creatorcontrib>Peeters, Annemiek M A</creatorcontrib><creatorcontrib>van Groningen, Marian C</creatorcontrib><creatorcontrib>Samsom, Janneke N</creatorcontrib><creatorcontrib>Maat, Alexander P W M</creatorcontrib><creatorcontrib>Betjes, Michiel G H</creatorcontrib><creatorcontrib>Weimar, Willem</creatorcontrib><creatorcontrib>Baan, Carla C</creatorcontrib><title>Thymus-Derived Regulatory T Cells Infiltrate the Cardiac Allograft Before Rejection</title><title>Transplantation</title><addtitle>Transplantation</addtitle><description>FOXP3+ regulatory T cells (Treg) either originate in the thymus (natural [n]Treg) or are induced in the periphery by antigen exposure and cytokines (induced [i]Treg). It is currently not elucidated which and to what extent these Treg subsets regulate intracardiac allogeneic responses in transplant patients.
By using demethylation of the Treg-specific demethylated region in the FOXP3 gene as a marker for nTreg and FOXP3 messenger RNA expression as a marker for the total Treg population, we examined Treg in endomyocardial biopsies (EMBs) of both patients who developed an acute rejection necessitating therapy (rejectors; International Society for Heart and Lung Transplantation rejection grade ≥ 2R) and patients who remained free from rejection (nonrejectors).
In the presence of comparable messenger RNA levels of CD3, IL-10, TGFβ, IL2, IFNγ, and IL17A, the percentage of nTreg was significantly higher in EMB with histological signs of mild rejection (rejection grade 1R) collected before rejection than in 1R EMB of nonrejectors. The total Treg population was comparable in 1R EMB of nonrejectors and 1R EMB collected before rejection, which suggests the presence of iTreg in the EMB of nonrejectors. The relative high percentage of nTreg after rejection was not related to the number of rejections, whereas the total Treg population was inversely related to the number of rejections the first year after transplantation.
Our data indicate that intragraft nTreg are unable to restrain alloreactivity leading to rejection. Moreover, the indirect evidence of the presence of intragraft iTreg suggests a possible role of iTreg in the regulation of alloreactivity.</description><subject>Acute Disease</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Biopsy</subject><subject>Chemotaxis, Leukocyte</subject><subject>DNA Methylation</subject><subject>Female</subject><subject>Forkhead Transcription Factors - genetics</subject><subject>Genetic Markers</subject><subject>Graft Rejection - drug therapy</subject><subject>Graft Rejection - genetics</subject><subject>Graft Rejection - immunology</subject><subject>Graft Rejection - pathology</subject><subject>Heart Transplantation - adverse effects</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardium - immunology</subject><subject>Myocardium - pathology</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>RNA, Messenger - genetics</subject><subject>T-Lymphocytes, Regulatory - immunology</subject><subject>Thymocytes - immunology</subject><issn>0041-1337</issn><issn>1534-6080</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkN9LwzAQx4Mobk7_AkHy6Etn0jRN-jjnr8HAofW5pMl162jXmaTC_nsjmyI-eS_Hwed7d3wQuqRkTEkmbvLFmPwuwcgRGlLOkiglkhyjISEJjShjYoDOnFsHhjMhTtEg5lKmGRVD9Jqvdm3vojuw9QcY_ALLvlG-szuc4yk0jcOzTVU33ioP2K8AT5U1tdJ40jTd0qrK41uoOgshugbt625zjk4q1Ti4OPQRenu4z6dP0fz5cTadzCPNpPRRlZAkJnFaMpEJXQpaGc44cGVKo02YS8FAx0IawQmHhJk40yUvS2mkJiJmI3S937u13XsPzhdt7XT4WW2g611BRcqzLJD8HyiRlMvgLqBsj2rbOWehKra2bpXdFZQUX-KLfFH8FR9SV4cDfdmC-cl8m2afG4p9RQ</recordid><startdate>201509</startdate><enddate>201509</enddate><creator>Boer, Karin</creator><creator>Caliskan, Kadir</creator><creator>Peeters, Annemiek M A</creator><creator>van Groningen, Marian C</creator><creator>Samsom, Janneke N</creator><creator>Maat, Alexander P W M</creator><creator>Betjes, Michiel G H</creator><creator>Weimar, Willem</creator><creator>Baan, Carla C</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>201509</creationdate><title>Thymus-Derived Regulatory T Cells Infiltrate the Cardiac Allograft Before Rejection</title><author>Boer, Karin ; Caliskan, Kadir ; Peeters, Annemiek M A ; van Groningen, Marian C ; Samsom, Janneke N ; Maat, Alexander P W M ; Betjes, Michiel G H ; Weimar, Willem ; Baan, Carla C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c388t-f4042026b3797cb71fd535e5adbdcdb71b73ec278d7505e43d29cb5bb8d8c0723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acute Disease</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Biopsy</topic><topic>Chemotaxis, Leukocyte</topic><topic>DNA Methylation</topic><topic>Female</topic><topic>Forkhead Transcription Factors - genetics</topic><topic>Genetic Markers</topic><topic>Graft Rejection - drug therapy</topic><topic>Graft Rejection - genetics</topic><topic>Graft Rejection - immunology</topic><topic>Graft Rejection - pathology</topic><topic>Heart Transplantation - adverse effects</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardium - immunology</topic><topic>Myocardium - pathology</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>RNA, Messenger - genetics</topic><topic>T-Lymphocytes, Regulatory - immunology</topic><topic>Thymocytes - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boer, Karin</creatorcontrib><creatorcontrib>Caliskan, Kadir</creatorcontrib><creatorcontrib>Peeters, Annemiek M A</creatorcontrib><creatorcontrib>van Groningen, Marian C</creatorcontrib><creatorcontrib>Samsom, Janneke N</creatorcontrib><creatorcontrib>Maat, Alexander P W M</creatorcontrib><creatorcontrib>Betjes, Michiel G H</creatorcontrib><creatorcontrib>Weimar, Willem</creatorcontrib><creatorcontrib>Baan, Carla C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boer, Karin</au><au>Caliskan, Kadir</au><au>Peeters, Annemiek M A</au><au>van Groningen, Marian C</au><au>Samsom, Janneke N</au><au>Maat, Alexander P W M</au><au>Betjes, Michiel G H</au><au>Weimar, Willem</au><au>Baan, Carla C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thymus-Derived Regulatory T Cells Infiltrate the Cardiac Allograft Before Rejection</atitle><jtitle>Transplantation</jtitle><addtitle>Transplantation</addtitle><date>2015-09</date><risdate>2015</risdate><volume>99</volume><issue>9</issue><spage>1839</spage><epage>1846</epage><pages>1839-1846</pages><issn>0041-1337</issn><eissn>1534-6080</eissn><abstract>FOXP3+ regulatory T cells (Treg) either originate in the thymus (natural [n]Treg) or are induced in the periphery by antigen exposure and cytokines (induced [i]Treg). It is currently not elucidated which and to what extent these Treg subsets regulate intracardiac allogeneic responses in transplant patients.
By using demethylation of the Treg-specific demethylated region in the FOXP3 gene as a marker for nTreg and FOXP3 messenger RNA expression as a marker for the total Treg population, we examined Treg in endomyocardial biopsies (EMBs) of both patients who developed an acute rejection necessitating therapy (rejectors; International Society for Heart and Lung Transplantation rejection grade ≥ 2R) and patients who remained free from rejection (nonrejectors).
In the presence of comparable messenger RNA levels of CD3, IL-10, TGFβ, IL2, IFNγ, and IL17A, the percentage of nTreg was significantly higher in EMB with histological signs of mild rejection (rejection grade 1R) collected before rejection than in 1R EMB of nonrejectors. The total Treg population was comparable in 1R EMB of nonrejectors and 1R EMB collected before rejection, which suggests the presence of iTreg in the EMB of nonrejectors. The relative high percentage of nTreg after rejection was not related to the number of rejections, whereas the total Treg population was inversely related to the number of rejections the first year after transplantation.
Our data indicate that intragraft nTreg are unable to restrain alloreactivity leading to rejection. Moreover, the indirect evidence of the presence of intragraft iTreg suggests a possible role of iTreg in the regulation of alloreactivity.</abstract><cop>United States</cop><pmid>25886917</pmid><doi>10.1097/TP.0000000000000730</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-1337 |
ispartof | Transplantation, 2015-09, Vol.99 (9), p.1839-1846 |
issn | 0041-1337 1534-6080 |
language | eng |
recordid | cdi_proquest_miscellaneous_1765990725 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Acute Disease Adolescent Adult Aged Biopsy Chemotaxis, Leukocyte DNA Methylation Female Forkhead Transcription Factors - genetics Genetic Markers Graft Rejection - drug therapy Graft Rejection - genetics Graft Rejection - immunology Graft Rejection - pathology Heart Transplantation - adverse effects Humans Immunohistochemistry Immunosuppressive Agents - therapeutic use Male Middle Aged Myocardium - immunology Myocardium - pathology Real-Time Polymerase Chain Reaction RNA, Messenger - genetics T-Lymphocytes, Regulatory - immunology Thymocytes - immunology |
title | Thymus-Derived Regulatory T Cells Infiltrate the Cardiac Allograft Before Rejection |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T11%3A13%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thymus-Derived%20Regulatory%20T%20Cells%20Infiltrate%20the%20Cardiac%20Allograft%20Before%20Rejection&rft.jtitle=Transplantation&rft.au=Boer,%20Karin&rft.date=2015-09&rft.volume=99&rft.issue=9&rft.spage=1839&rft.epage=1846&rft.pages=1839-1846&rft.issn=0041-1337&rft.eissn=1534-6080&rft_id=info:doi/10.1097/TP.0000000000000730&rft_dat=%3Cproquest_cross%3E1765990725%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1708158534&rft_id=info:pmid/25886917&rfr_iscdi=true |